Study on natural language processing and machine learning to develop oncology decision aid for multiple myeloma in Alberta In Canada, approximately 2,900 people were diagnosed with multiple myeloma in 2017. Unique, targeted therapies are currently in development for...
Category
Medlior awarded inaugural Women’s Entrepreneurship Fund from Government of Canada
Fund awarded to Canadian women entrepreneurs to provide market opportunities and support growth Calgary, Alberta (May 20, 2019) - Calgary based company, Medlior Health Outcomes Research Ltd., has been awarded the Women Entrepreneurship Fund by the Government of...
Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease
Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease In a large retrospective study, investigators identify a significant treatment gap in managing patients with and at risk for clinical atherosclerotic...
Canadian firm Medlior impacts global health research with launch of Real World Radar directory
Canadian firm Medlior impacts global health research with launch of Real World Radar directory Comprehensive listing of Real World Datasets is first of its kind Calgary, Alberta - (May 3, 2019) Medlior Health Outcomes Research Ltd. is positively impacting global...